Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report-Reference-Cited by-同舟云学术

Conversion Surgery for Advanced Thoracic SMARCA4-Deficient Undifferentiated Tumor With Atezolizumab in Combination With Bevacizumab, Paclitaxel, and Carboplatin Treatment: A Case Report

Published:2021-11 Issue:11 Volume:2 Page:100235
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Kunimasa Kei^ORCID,Okami Jiro,Takenaka Satoshi,Honma Keiichiro,Kukita Yoji,Nagata Shigenori,Kawamura Takahisa,Inoue Takako,Tamiya Motohiro,Kuhara Hanako,Nishino Kazumi,Tahara Hideaki,Kumagai Toru

Funder

Takeda Science Foundation

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas;Rekhtman;J Thorac Oncol,2020

2. Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumor;Henon;Ann Oncol,2019

3. Atezolizumab with bevacizumab, paclitaxel and carboplatin was effective for patients with SMARCA4-deficient thoracic sarcoma;Kawachi;Immunotherapy,2021

4. KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden;Marinelli;Ann Oncol,2020

5. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMARCA4‑deficient uterine adnexal tumor with ascites: A case report and literature review;Oncology Letters;2024-06-05

2. Successful treatment with tislelizumab plus chemotherapy for SMARCA4-deficient undifferentiated tumor: a case report;Frontiers in Immunology;2024-05-31

3. A Rare Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor With Diffuse Brain Metastasis;Cureus;2024-05-30

4. Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go;International Journal of Molecular Sciences;2024-03-13

5. Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies;Clinical Cancer Research;2023-12-07